top of page

About Me

My name is Cornelius Enuezie and I am the founder of COZAREN GmbH and I come with over 27 years of biopharmaceutical experience (notably, at Novartis, IMS Health, Teva and Clarivate). I have an excellent record of generating economic value by leveraging patent portfolio and technical knowledge and implementing portfolio optimisation strategies to identify hidden patent monetisation opport​unities, increase patent portfolio value and reduce management costs, thus enabling organisations to focus on core business strengths and interests. 


For more my LinkedIn profile, please click here.

Qualifications:

  • Doctorate in Business Administration (DBA);
  • Master of Laws (LLM) in Patent and Technology Law; and,
  • Bachelor of Science degree in Industrial Chemistry.


I also have expert knowledge of myriad pharmaceutical information and patent searching databases, including CAS Registry, DWPI, SequenceBase (GENESEQ), Cortellis, Cortellis Drug Discovery Intelligence (CDDI) and GlobalData databases, as well freely-available patent databases provided by patent offices. Please refer to my areas of expertise below.

Publications:

Click here for my latest article in les Nouvelles on Business research skills for facilitating non-core out-licensing, which was voted the article of the month of October 2021.



Portfolio management

We conduct:
  • portfolio audits to identify licensing/monetisation opportunities and areas for achieving cost savings;
  • biopharmaceutical competitor and market intelligence analyses;
  • patent portfolio valuations;
  • clinical and regulatory insights into biopharmaceutical R&D activities; and
  • product pricing and forecasting analyses.

Commercial research

We identify:
  • licensees, new markets and R&D collaborators;
  • untapped R&D and commercial opportunities; and,
  • litigation/infringement risks.

Patent search

We conduct:
  • chemical and biological novelty, validity, landscape and FTO searches.

Case law to:

We: 
  • support patent prosecution and litigation;
  • conduct due diligence, risk analyses (including anti-trust scrutiny); and,
  • prepare business and legal case to support patent infringement enforcement.
bottom of page